Arbutus Biopharma Corp. (ABUS)
4.20
-0.01
(-0.24%)
USD |
NASDAQ |
Oct 23, 16:00
4.20
0.00 (0.00%)
After-Hours: 20:00
Arbutus Biopharma Price : 4.20 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 4.17 | 4.22 | 4.121 | 4.20 | 2.029M |
| Oct 22, 2026 | 4.22 | 4.37 | 4.175 | 4.21 | 2.464M |
| Oct 21, 2026 | 4.32 | 4.35 | 4.17 | 4.18 | 3.026M |
| Oct 20, 2026 | 4.24 | 4.365 | 4.22 | 4.33 | 2.114M |
| Oct 19, 2026 | 4.24 | 4.28 | 4.15 | 4.23 | 1.959M |
| Oct 16, 2026 | 4.29 | 4.29 | 4.18 | 4.22 | 4.542M |
| Oct 15, 2026 | 4.23 | 4.30 | 4.215 | 4.29 | 2.277M |
| Oct 14, 2026 | 4.07 | 4.25 | 4.05 | 4.19 | 2.434M |
| Oct 13, 2026 | 4.13 | 4.155 | 4.05 | 4.11 | 3.482M |
| Oct 12, 2026 | 4.20 | 4.23 | 4.12 | 4.15 | 2.343M |
| Oct 09, 2026 | 4.17 | 4.27 | 4.13 | 4.22 | 3.146M |
| Oct 08, 2026 | 4.22 | 4.30 | 4.05 | 4.18 | 4.855M |
| Oct 07, 2026 | 4.46 | 4.48 | 4.28 | 4.29 | 4.791M |
| Oct 06, 2026 | 4.67 | 4.67 | 4.43 | 4.48 | 8.260M |
| Oct 05, 2026 | 4.45 | 4.80 | 4.41 | 4.67 | 6.183M |
| Oct 02, 2026 | 4.55 | 4.68 | 4.375 | 4.45 | 8.987M |
| Oct 01, 2026 | 4.77 | 4.775 | 4.51 | 4.56 | 16.12M |
| Sep 30, 2026 | 4.675 | 4.95 | 4.675 | 4.78 | 16.88M |
| Sep 29, 2026 | 4.86 | 4.89 | 4.67 | 4.69 | 17.56M |
| Sep 28, 2026 | 4.84 | 4.88 | 4.80 | 4.86 | 11.67M |
| Sep 25, 2026 | 4.89 | 4.93 | 4.84 | 4.85 | 16.88M |
| Sep 24, 2026 | 4.85 | 4.885 | 4.801 | 4.88 | 6.263M |
| Sep 23, 2026 | 5.01 | 5.02 | 4.84 | 4.85 | 10.84M |
| Sep 22, 2026 | 5.02 | 5.05 | 4.995 | 5.01 | 10.49M |
| Sep 21, 2026 | 5.03 | 5.07 | 4.99 | 5.00 | 4.563M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Gossamer Bio, Inc. | 9.605 |
| Legend Biotech Corp. | 19.27 |
| ACADIA Pharmaceuticals, Inc. | 19.73 |
| Alnylam Pharmaceuticals, Inc. | 224.03 |
| Anika Therapeutics, Inc. | 21.42 |
Price Related Metrics
| PE Ratio | 5.361 |
| PS Ratio | 4.490 |
| Price to Book Value | 3.208 |
| Earnings Yield | 18.65% |
| Market Cap | 830.06M |
| Operating PE Ratio | 5.534 |
| Normalized PE Ratio | 5.401 |